December 12, 2017 : DCMS #375

DISASTERS AVERTED — Near Miss Case Studies

Travel: When Should You Not Avoid Pain?

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Aaron Vinik Part 6, Early Signs of Heart Disease

HOMERUN SLIDES — Great Clinical Presentation Highlights

Diabetes 2017 Part 5

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #103: Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Part 1

MOST POPULAR ARTICLES OF THE MONTH

#1 1-Hour Post-Prandial Glucose Predicts Risk For Type 2 Diabetes
#2 Type 1 Cured in Mice
#3 Vitamin D’s Role In Preventing Type 1 Diabetes

Today I watched a news feature on the use of robots as supervisors of humans doing jobs.

Last week another show listed jobs that robots would do, and unfortunately pharmacists was one of those jobs. When you add in driverless cars and drone delivery it is not hard to see where things are going.

The same technology will also manage diabetes in the near future, and this week our Homerun Slides look at the technology of diabetes care now and into the future.

Dave Joffe

Editor-in-chief

I traveled to Europe, a continent with a lot of history and cobblestone streets. I was aware of the amount of walking I was going to do and reminded myself of what we teach, or should be teaching, our patients: Do not travel with new shoes only. Always bring a pair of tried and true. And when you do buy new shoes, buy them later in the day, make sure they fit well, and break them in before wearing for long periods at a time. Wear them about a half hour a day, then slowly increase the time you wear your shoes to avoid foot problems.

In part 6 of this Exclusive Interview, Dr. Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the ability to predict cardiovascular disease.

In this week’s Homerun Slides, the technology currently and soon to be helping people to manage their diabetes.

Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver disease ranging from simple liver fat accumulation to severe hepatic necro-inflammation (nonalcoholic steatohepatitis or NASH), and eventually cirrhosis.

Study finds diabetes complications and mortality may be better predicted with elevated 1-hour blood glucose levels compared with 2-hour blood glucose levels.

Ralph DeFronzo and his researchers at UT Health at San Antonio announced that they have cured type 1 diabetes.

Vitamin D supplementation could possibly reduce the risk of type 1 diabetes in susceptible children.